Immune system versus tumor: shifting the balance in favor of DCs and effective immunity.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 14991063.
- Also identified by PMC identifier 351327.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite the initial excitement over cancer vaccines, the clinical effectiveness of immunotherapy has been disappointing. The suppressive milieu present within established tumors inhibits effective immune responses, although new strategies are emerging to manipulate the local tumor microenvironment and shift the balance back to a proinflammatory environment, promote DC activation, and enhance tumor immunity.
Medical subject headings
- Dendritic Cells
- Neoplasms